Biotech

All Articles

Vaccine and Keytruda combo reliable in squamous cell carcinoma

.Invulnerable gate preventions are the superheroes of cancer treatment. Drugs like Bristol Myers Squ...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and a...

Regeneron's Opdualag rival reveals 57% reaction rate

.Regeneron is actually back with long-lasting follow-up for its LAG-3 prevention and PD-1 inhibitor ...

AstraZeneca articles records on internal competitors to AbbVie, Pfizer ADCs

.AstraZeneca has actually shared an early consider the functionality of its own internal antibody-dr...

iTeos- GSK's TIGIT star presents significant renovation

.After revealing a period 3 launch based on good midstage outcomes, iTeos and GSK are lastly sharing...

More collaborative FDA can easily accelerate unusual condition R&ampD: file

.The FDA should be even more open and also collaborative to unleash a surge in commendations of unco...

Zenas, MBX, Bicara scalp to Nasdaq in warm day for biotech IPOs

.It's an uncommonly hectic Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Reha...

Atea's COVID antiviral stops working to halt hospitalizations in stage 3

.Atea Pharmaceuticals' antiviral has neglected one more COVID-19 trial, yet the biotech still keeps ...

Neurocrine's proposal to spare mental illness possibility neglects

.Neurocrine Biosciences' mental illness course pivot has actually fallen short. The biotech was actu...

Sanofi pays for $110M upfront for late-stage radioligand therapy

.Sanofi has brought in a late access to the radioligand event, spending 100 thousand europeans ($ 11...